GR3015737T3 - Multi-layered controlled release formulation. - Google Patents

Multi-layered controlled release formulation.

Info

Publication number: GR3015737T3
Authority: GR; Greece
Prior art keywords: controlled release; layered; release formulation; sustainably; periphery
Prior art date: 1991-05-20

Application number

GR950400870T

Other languages

English (en)

Inventor

Kazuo Noda

Hiroyuki Yoshino

Yoshiyuki Hirakawa

David D Maclaren

Paul F Skultety

John R Lefler

Greg M Beck

Original Assignee

Marion Laboratories Inc

Tanabe Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-20

Filing date

1995-04-10

Publication date

1995-07-31

1995-04-10 Application filed by Marion Laboratories Inc, Tanabe Seiyaku Co filed Critical Marion Laboratories Inc

1995-07-31 Publication of GR3015737T3 publication Critical patent/GR3015737T3/el

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Farming Of Fish And Shellfish (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

GR950400870T 1991-05-20 1995-04-10 Multi-layered controlled release formulation. GR3015737T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70285491A	1991-05-20	1991-05-20
PCT/US1992/004267 WO1992020326A1 (en)	1991-05-20	1992-05-20	Multi-layered controlled release formulation

Publications (1)

Publication Number	Publication Date
GR3015737T3 true GR3015737T3 (en)	1995-07-31

Family

ID=24822867

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR950400870T GR3015737T3 (en)	1991-05-20	1995-04-10	Multi-layered controlled release formulation.

Country Status (11)

Country	Link
US (1)	US5320853A (el)
EP (1)	EP0585355B1 (el)
JP (1)	JP3426230B2 (el)
AT (1)	ATE120089T1 (el)
AU (1)	AU2016992A (el)
DE (1)	DE69201793T2 (el)
DK (1)	DK0585355T3 (el)
ES (1)	ES2073301T3 (el)
GR (1)	GR3015737T3 (el)
NZ (1)	NZ242806A (el)
WO (1)	WO1992020326A1 (el)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU653026B2 (en) *	1991-06-07	1994-09-15	Teikoku Seiyaku Kabushiki Kaisha	Physiologically active polypeptide-containing pharmaceutical composition
US5376384A (en) *	1992-12-23	1994-12-27	Kinaform Technology, Inc.	Delayed, sustained-release pharmaceutical preparation
AU7966694A (en) *	1993-07-21	1996-05-02	University Of Kentucky Research Foundation, The	A multicompartment hard capsule with control release properties
US5395626A (en) *	1994-03-23	1995-03-07	Ortho Pharmaceutical Corporation	Multilayered controlled release pharmaceutical dosage form
US5645858A (en) *	1994-10-06	1997-07-08	Ortho Pharmaceutical Corporation	Multilayered controlled release pharmaceutical dosage form
US6156343A (en) *	1994-12-27	2000-12-05	Akzo Nobel N.V.	Controlled release preparation
US5834024A (en)	1995-01-05	1998-11-10	Fh Faulding & Co. Limited	Controlled absorption diltiazem pharmaceutical formulation
FR2754177B1 (fr) *	1996-10-07	1999-08-06	Sanofi Sa	Microspheres pharmaceutiques d'acide valproique pour administration orale
US5885616A (en) *	1997-08-18	1999-03-23	Impax Pharmaceuticals, Inc.	Sustained release drug delivery system suitable for oral administration
US6602521B1 (en)	1998-09-29	2003-08-05	Impax Pharmaceuticals, Inc.	Multiplex drug delivery system suitable for oral administration
AU764453B2 (en)	1999-10-29	2003-08-21	Euro-Celtique S.A.	Controlled release hydrocodone formulations
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
US7220430B2 (en)	2000-01-27	2007-05-22	Tanabe Seiyaku Co., Ltd.	Sustained-release preparation and process for producing the same
US6635277B2 (en)	2000-04-12	2003-10-21	Wockhardt Limited	Composition for pulsatile delivery of diltiazem and process of manufacture
CN101317825A (zh)	2000-10-30	2008-12-10	欧罗赛铁克股份有限公司	控释氢可酮制剂
US20030181488A1 (en) *	2002-03-07	2003-09-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
GB0310919D0 (en) *	2003-05-13	2003-06-18	West Pharm Serv Drug Res Ltd	Pharmaceutical compositions
ES2228267B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
ES2228268B1 (es) *	2003-07-30	2006-07-01	Laboratorios Del Dr. Esteve, S.A.	Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
JP4468669B2 (ja) *	2003-09-22	2010-05-26	久光製薬株式会社	低刺激性貼付剤
DE10353196A1 (de) *	2003-11-13	2005-06-16	Röhm GmbH & Co. KG	Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
DE10353186A1 (de) *	2003-11-13	2005-06-16	Röhm GmbH & Co. KG	Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
CN1993112A (zh) *	2004-07-29	2007-07-04	赛诺菲-安万特	用于具有高度pH依赖性溶解度的活性成分的控释的药物多层片剂
WO2006055886A2 (en)	2004-11-19	2006-05-26	Smithkline Beecham Corporation	Method for customized dispensing of variable dose drug combination products for individualizing of therapies
CA2640382C (en) *	2006-01-27	2015-12-29	Eurand, Inc	Drug delivery systems comprising weakly basic drugs and organic acids
CN103211779B (zh) *	2006-01-27	2016-03-16	阿代尔制药股份有限公司	包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送***
WO2008094877A2 (en) *	2007-01-30	2008-08-07	Drugtech Corporation	Compositions for oral delivery of pharmaceuticals
EP3050568B1 (en)	2007-03-13	2020-12-02	JDS Therapeutics, LLC	Methods and compositions for the sustained release of chromium
WO2008112388A1 (en)	2007-03-14	2008-09-18	Drugtech Corporation	Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
US8623397B2 (en) *	2007-04-13	2014-01-07	The Regents Of The University Of Michigan	Delivery device and method for forming the same
WO2009002867A2 (en)	2007-06-26	2008-12-31	Nutrition 21, Inc.	Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US8133506B2 (en) *	2008-03-12	2012-03-13	Aptalis Pharmatech, Inc.	Drug delivery systems comprising weakly basic drugs and organic acids
US20110003005A1 (en) *	2009-07-06	2011-01-06	Gopi Venkatesh	Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
CA2902911C (en)	2014-10-31	2017-06-27	Purdue Pharma	Methods and compositions particularly for treatment of attention deficit disorder
MX2018009748A (es)	2016-02-11	2019-02-07	Nutrition 21 Llc	Composiciones que contienen cromo para mejorar la salud y el estado físico.
US10722473B2 (en)	2018-11-19	2020-07-28	Purdue Pharma L.P.	Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB768512A (en) *	1954-08-16	1957-02-20	Smith Kline & French Internat	Improvements in or relating to pharmaceutical tablets
GB874586A (en) *	1957-10-28	1961-08-10	Upjohn Co	Improvements in or relating to therapeutic compositions and the manufacture thereof
US2928770A (en) *	1958-11-28	1960-03-15	Frank M Bardani	Sustained action pill
US3562257A (en) *	1967-10-28	1971-02-09	Tanabe Seiyaku Co	Benzothiazepine derivatives
GB1346610A (el) *	1971-07-02	1974-02-13
US3954959A (en) *	1973-03-28	1976-05-04	A/S Alfred Benzon	Oral drug preparations
GB1468172A (en) *	1973-03-28	1977-03-23	Benzon As Alfred	Oral drug preparations
DE2802114A1 (de) *	1978-01-19	1979-07-26	Sandoz Ag	Neue pharmazeutische zusammensetzung und verfahren zu deren herstellung
DD146547A5 (de) *	1978-07-15	1981-02-18	Boehringer Sohn Ingelheim	Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE2950977A1 (de) *	1978-12-22	1980-07-10	Donald E Panoz	Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
DE3000979A1 (de) *	1980-01-12	1981-07-23	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) *	1981-06-19	1983-01-05	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue orale dipyridamolformen
DE3126703A1 (de) *	1981-07-07	1983-01-27	Dr. Karl Thomae Gmbh, 7950 Biberach	Bromhexin-retardform und verfahren zu ihrer herstellung
DE3237575A1 (de) *	1982-10-09	1984-04-12	Dr. Karl Thomae Gmbh, 7950 Biberach	Neue orale mopidamolformen
IE55745B1 (en) *	1983-04-06	1991-01-02	Elan Corp Plc	Sustained absorption pharmaceutical composition
US4567175A (en) *	1983-06-03	1986-01-28	Tanabe Seiyaku Co., Ltd.	8-Chloro-1,5-benzothiazepine derivatives
JPS6051106A (ja) *	1983-08-31	1985-03-22	Yamanouchi Pharmaceut Co Ltd	塩酸アモスラロ−ル持続性製剤
IE56459B1 (en) *	1983-12-21	1991-08-14	Elan Corp Ltd	Controlled absorption pharmaceutical formulation
IE56999B1 (en) *	1983-12-22	1992-03-11	Elan Corp Plc	Pharmaceutical formulation
US4894240A (en) *	1983-12-22	1990-01-16	Elan Corporation Plc	Controlled absorption diltiazem formulation for once-daily administration
JPS615010A (ja) *	1984-06-18	1986-01-10	Tooa Eiyoo Kk	水素添加麦角アルカロイド徐放性製剤及びその製法
US4610870A (en) *	1984-10-05	1986-09-09	E. R. Squibb & Sons, Inc.	Controlled release formulation
SE455836B (sv) *	1985-10-11	1988-08-15	Haessle Ab	Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
JPS62114910A (ja) *	1985-11-13	1987-05-26	エラン　コ−ポレ−シヨン　ピ−　エル　シ−	吸収がコントロ−ルされた医薬製剤
DE3856555T2 (de) *	1987-10-16	2004-04-29	Elan Corp. Plc	Diltiazem-Zusammensetzungen mit kontrollierter Wirkstoffabsorption
GB8724763D0 (en) *	1987-10-22	1987-11-25	Aps Research Ltd	Sustained-release formulations
IL88083A (en) *	1987-11-06	1992-11-15	Tanabe Seiyaku Co	Controlled release pharmaceutical dosage form and its preparation
FI101344B1 (fi) *	1988-03-31	1998-06-15	Tanabe Seiyaku Co	Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
DE3812799A1 (de) *	1988-04-16	1989-10-26	Sanol Arznei Schwarz Gmbh	Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
JPH0674206B2 (ja) *	1989-12-28	1994-09-21	田辺製薬株式会社	放出制御型製剤およびその製法

1992
- 1992-05-20 ES ES92912145T patent/ES2073301T3/es not_active Expired - Lifetime
- 1992-05-20 AU AU20169/92A patent/AU2016992A/en not_active Abandoned
- 1992-05-20 DK DK92912145.7T patent/DK0585355T3/da active
- 1992-05-20 JP JP50028993A patent/JP3426230B2/ja not_active Expired - Lifetime
- 1992-05-20 NZ NZ242806A patent/NZ242806A/en not_active IP Right Cessation
- 1992-05-20 DE DE69201793T patent/DE69201793T2/de not_active Expired - Lifetime
- 1992-05-20 WO PCT/US1992/004267 patent/WO1992020326A1/en active IP Right Grant
- 1992-05-20 EP EP92912145A patent/EP0585355B1/en not_active Expired - Lifetime
- 1992-05-20 AT AT92912145T patent/ATE120089T1/de active
- 1992-12-22 US US07/995,309 patent/US5320853A/en not_active Expired - Lifetime
1995
- 1995-04-10 GR GR950400870T patent/GR3015737T3/el unknown

Also Published As

Publication number	Publication date
EP0585355A1 (en)	1994-03-09
ATE120089T1 (de)	1995-04-15
JPH06507903A (ja)	1994-09-08
JP3426230B2 (ja)	2003-07-14
EP0585355B1 (en)	1995-03-22
ES2073301T3 (es)	1995-08-01
AU2016992A (en)	1992-12-30
WO1992020326A1 (en)	1992-11-26
DE69201793D1 (de)	1995-04-27
US5320853A (en)	1994-06-14
DE69201793T2 (de)	1995-09-21
DK0585355T3 (da)	1995-06-06
NZ242806A (en)	1994-01-26

Publication	Publication Date	Title
GR3015737T3 (en)	1995-07-31	Multi-layered controlled release formulation.
NO305886B1 (no)	1999-08-16	Anvendelse av et organisk nitritt for fremstilling av medikamenter for kontinuerlig, vasodilatorisk terapi
NO904492D0 (no)	1990-10-17	Fremgangsmaate for fremstilling av et aerosolpreparat for topisk anvendelse.
CA2163003A1 (en)	1994-11-24	Solubilizer and external preparations containing the same
DE69233776D1 (de)	2009-12-31	Verwendung einer 1,3 Oxathiolannukleosid-analogen Verbindung zur Herstellung eines Arzneimittels zur spezifischen Verabreichung
AU2250788A (en)	1989-03-01	Respiratory mask
NO911934L (no)	1991-11-20	Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner.
NO894712D0 (no)	1989-11-27	Organopolysiloksan-blanding for dannelse av en sperrefilm.
NZ333514A (en)	2000-05-26	Oral pharmaceutical composition comprising a triazole antifungal compound
FI881191A (fi)	1988-09-21	Kompakt maskin foer framstaellning av cigarretter.
FI892960A0 (fi)	1989-06-16	Foerfarande och anordning foer definiering av kanternas laege i roerliga band.
ES2059464T3 (es)	1994-11-16	Formas especificamente dirigidas de agentes antitumorales de metiltritio.
AU2097988A (en)	1989-02-16	Imidazo (1,2-b) pyridazin-2-yl carbamate derivatives
HK22997A (en)	1997-02-27	Substituted 4-phenyl-4-piperidine-carboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
GB0010446D0 (en)	2000-06-14	Pharmaceutical formulation
CA2094424A1 (en)	1993-10-25	Method of treating osteoporosis with 1.alpha.,24(r)-dihydroxy-22(e)-dehydro-vitamin d3
NO993627D0 (no)	1999-07-26	Anvendelse av en forbindelse for fremstilling av et legemiddel
BG102692A (en)	1999-04-30	Pharmaceutical forms with delayed release, containing misolastin
ITMI942483A0 (it)	1994-12-09	Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
AU3389093A (en)	1993-09-09	Pharmaceutical coated cores
MY114213A (en)	2002-08-30	Clavulanic acid salts
ES2001290A6 (es)	1988-05-01	Procedimiento para aislar (+)-6-cloro-5,10-dihidro-5-(1-metil-4-piperidil)-acetil)-11h-dibenzo(b,e)-(1,4)-diazepin-11-ona"
JPS5513252A (en)	1980-01-30	Preventive and remedy for swine dysentry
ZA976212B (en)	1998-03-23	Process for nitrosation of a phenolic compound substituted with an electron-withdrawing group and use thereof.
FI896048A0 (fi)	1989-12-18	5-fluormetyl-1,2,4-triazolo/1,5-a/ pyrimidin-2-sulfonamider, foerfaranden foer deras framstaellning och kompositioner foer deras anvaendning som herbicider.